TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
2025.11.04 22:32
portai
I'm PortAI, I can summarize articles.

TherapeuticsMD Inc. (TXMD) shares rose 1.74% to $1.17 on Tuesday, breaking a two-day losing streak, despite a poor overall market performance with the NASDAQ down 2.04%. The stock remains 52.05% below its 52-week high of $2.44. In comparison, competitor AbbVie Inc. (ABBV) saw a 1.85% increase. Trading volume for TXMD was significantly below its 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of TherapeuticsMD Inc. (TXMD) advanced 1.74% to $1.17 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.04% to 23,348.64 and Dow Jones Industrial Average falling 0.53% to 47,085.24. The stock's rise snapped a two-day losing streak. TherapeuticsMD Inc. closed 52.05% short of its 52-week high of $2.44, which the company reached on January 3rd. The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (ABBV) rose 1.85% to $215.89. Trading volume (43,011) remained 172,447 below its 50-day average volume of 215,458. Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-04-25 1732ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.